Profile
Harald Poth is currently the Chairman-Supervisory Board at Phenex Pharmaceuticals AG, Director at Acousia Therapeutics GmbH, and Senior Investment Manager at LBBW Venture Capital GmbH.
He holds a doctorate degree from the University of Hohenheim.
Harald Poth active positions
| Companies | Position | Start |
|---|---|---|
LBBW Venture Capital GmbH
LBBW Venture Capital GmbH Investment ManagersFinance LBBW Venture Capital invests in companies located in DACH region. The firm targets companies operating in the fields of disruptive information technology, life sciences, software, digital formation and fintech. It provides financing for seed and early stage capital requirements with an investment size up to EUR 3 million. | Private Equity Investor | - |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Specializes in identification and analysis of selective drug candidates for nuclear receptors using its SNuRM technology | Chairman | - |
Acousia Therapeutics GmbH
Acousia Therapeutics GmbH BiotechnologyHealth Technology Develops drugs for local application | Director/Board Member | - |
Training of Harald Poth
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
LBBW Venture Capital GmbH
LBBW Venture Capital GmbH Investment ManagersFinance LBBW Venture Capital invests in companies located in DACH region. The firm targets companies operating in the fields of disruptive information technology, life sciences, software, digital formation and fintech. It provides financing for seed and early stage capital requirements with an investment size up to EUR 3 million. | Finance |
University of Hohenheim
University of Hohenheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Specializes in identification and analysis of selective drug candidates for nuclear receptors using its SNuRM technology | Health Technology |
Acousia Therapeutics GmbH
Acousia Therapeutics GmbH BiotechnologyHealth Technology Develops drugs for local application | Health Technology |
- Stock Market
- Insiders
- Harald Poth
















